Edwards Lifesciences Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Okay. Good afternoon. We're back here. I'm Amit Hazan, the Goldman Sachs medtech analyst. And late afternoon session here, we have Edwards Lifesciences with us. We've got Scott Ullem, the Chief Financial Officer, here with us today. So first and foremost, Scott, busy time for everyone, so I just wanted to thank you for making it out to the conference virtually, and appreciate your time.
Yes, for sure. No, it's great to be here. Good to see you, Amit.
Questions & Answers
You too. And I thought, just given the news last night, maybe it's better, just right at the top, to give you a chance to frame the China approval in the right way. Just maybe talk through how that opportunity ramps from here, both in terms of opportunity and limitations to how -- what needs to happen.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
